No safety concerns, heart inflammation reports on Pfizer vaccine: UK regulator

Published: Updated:
Read Mode
100% Font Size
1 min read

There are no new safety concerns around the Pfizer COVID-19 vaccine and heart inflammation based on the rollout of the shot in Britain, the UK MHRA medicine regulator said on Wednesday, after cases of the condition in Israel.

For more coronavirus news, visit our dedicated page.

“The MHRA is as aware of the reports of myocarditis under investigation in Israel. Based on our experience and safety monitoring in the UK, there is currently no new safety concerns raised regarding myocarditis,” a MHRA spokeswoman said.

The comment echoed the US Centers for Disease Control and Prevention (CDC) which said it had not seen a link between the shot and heart inflammation.


Read more:

EU official warns of risks of disjointed COVID-19 vaccine records

Chinese vaccine makers consider combining COVID-19 jabs, booster shots

White House says it’s considering intellectual property waiver for COVID-19 vaccines

Top Content Trending